Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara

I. M. Balabanova; I. M. Fedorin; N. A. Malomanova; F. Drobnievskiǐ; V. V. Nikolaevskiǐ; H. Sun; I. A. Mashkova; T. G. Simak; I. S. Kontsevaia; O. A. Ignat'eva; S. A. Mironova

Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara

I. M. Balabanova^*
, I. M. Fedorin
, N. A. Malomanova
, F. Drobnievskiǐ
, V. V. Nikolaevskiǐ
, H. Sun
, I. A. Mashkova
, T. G. Simak
, I. S. Kontsevaia
, O. A. Ignat'eva
, S. A. Mironova

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

The paper gives the results of a demonstration project to introduce a test for drug sensitivity to second-line antituberculous agents for patients with multidrug-resistant (MDR) tuberculosis at a routine large Russian laboratory. Two hundred and thirty MDR isolates were examined; of them 8.7% had extreme drug resistance. The cost of this test was estimated to be US $ 33.4. The introduction of this test is possible and essential for the precise and timely choice of antituberculous therapy for patients with MDR tuberculosis.

Original language	English
Pages (from-to)	63-70
Number of pages	8
Journal	Problemy tuberkuleza i bolezneǐ legkikh
Issue number	10
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{200f97ecc1844ee28b89356c3a3dcfe9,

title = "Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara",

abstract = "The paper gives the results of a demonstration project to introduce a test for drug sensitivity to second-line antituberculous agents for patients with multidrug-resistant (MDR) tuberculosis at a routine large Russian laboratory. Two hundred and thirty MDR isolates were examined; of them 8.7\% had extreme drug resistance. The cost of this test was estimated to be US \$ 33.4. The introduction of this test is possible and essential for the precise and timely choice of antituberculous therapy for patients with MDR tuberculosis.",

author = "Balabanova, \{I. M.\} and Fedorin, \{I. M.\} and Malomanova, \{N. A.\} and F. Drobnievskiǐ and Nikolaevskiǐ, \{V. V.\} and H. Sun and Mashkova, \{I. A.\} and Simak, \{T. G.\} and Kontsevaia, \{I. S.\} and Ignat'eva, \{O. A.\} and Mironova, \{S. A.\}",

note = "Copyright: MEDLINE{\textregistered} is the source for the citation and abstract of this record.",

year = "2009",

language = "English",

pages = "63--70",

journal = "Problemy tuberkuleza i bolezneǐ legkikh",

issn = "1728-2993",

publisher = "Meditsina Publishers",

number = "10",

}

TY - JOUR

T1 - Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara

AU - Balabanova, I. M.

AU - Fedorin, I. M.

AU - Malomanova, N. A.

AU - Drobnievskiǐ, F.

AU - Nikolaevskiǐ, V. V.

AU - Sun, H.

AU - Mashkova, I. A.

AU - Simak, T. G.

AU - Kontsevaia, I. S.

AU - Ignat'eva, O. A.

AU - Mironova, S. A.

N1 - Copyright: MEDLINE® is the source for the citation and abstract of this record.

PY - 2009

Y1 - 2009

N2 - The paper gives the results of a demonstration project to introduce a test for drug sensitivity to second-line antituberculous agents for patients with multidrug-resistant (MDR) tuberculosis at a routine large Russian laboratory. Two hundred and thirty MDR isolates were examined; of them 8.7% had extreme drug resistance. The cost of this test was estimated to be US $ 33.4. The introduction of this test is possible and essential for the precise and timely choice of antituberculous therapy for patients with MDR tuberculosis.

AB - The paper gives the results of a demonstration project to introduce a test for drug sensitivity to second-line antituberculous agents for patients with multidrug-resistant (MDR) tuberculosis at a routine large Russian laboratory. Two hundred and thirty MDR isolates were examined; of them 8.7% had extreme drug resistance. The cost of this test was estimated to be US $ 33.4. The introduction of this test is possible and essential for the precise and timely choice of antituberculous therapy for patients with MDR tuberculosis.

UR - https://www.scopus.com/pages/publications/74949086454

M3 - Article

C2 - 20000083

AN - SCOPUS:74949086454

SN - 1728-2993

SP - 63

EP - 70

JO - Problemy tuberkuleza i bolezneǐ legkikh

JF - Problemy tuberkuleza i bolezneǐ legkikh

IS - 10

ER -

Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this